Statera Biopharma, Inc. Decrease in Restricted Cash
Statera Biopharma, Inc. reported Decrease in Restricted Cash of $0 for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Notes
us-gaap:DecreaseInRestrictedCash · last filed 2016-08-15
- Statera Biopharma, Inc. decrease in restricted cash for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Statera Biopharma, Inc. decrease in restricted cash for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Statera Biopharma, Inc. decrease in restricted cash for the quarter ending 2015-12-31 was $20.35K.
- Statera Biopharma, Inc. decrease in restricted cash for the quarter ending 2015-09-30 was -$448.24K.
- Statera Biopharma, Inc. decrease in restricted cash for fiscal 2015 was $407.10K.
- Statera Biopharma, Inc. decrease in restricted cash for fiscal 2014 was $0.00.
| Period end | Decrease in Restricted Cash 3 month | Decrease in Restricted Cash 6 month | Decrease in Restricted Cash 9 month | Decrease in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $20.35K derived: sum of 3 quarters · filed 2016-08-15 | -$427.89K derived: sum of 4 quarters · filed 2016-08-15 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 | $20.35K derived: sum of 2 quarters · filed 2016-05-16 | -$427.89K derived: sum of 3 quarters · filed 2016-05-16 | -$363.51K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-12-31 | $20.35K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$427.89K derived: sum of 2 quarters · filed 2016-02-23 | -$363.51K derived: sum of 3 quarters · filed 2016-08-15 | $407.10K 10-K · filed 2016-02-23 |
| 2015-09-30 | -$448.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$383.86K derived: sum of 2 quarters · filed 2016-08-15 | $386.75K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $64.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $834.99K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $770.61K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-02-23 |